Oppenheimer raised the firm’s price target on Target to $200 from $170 and keeps an Outperform rating on the shares. The firm believes the potential for a continued positive earnings revision cycle, a still accommodative valuation, and mixed investor sentiment towards the story could drive further outperformance from here, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TGT:
- High Benzene Levels Found in Multiple Brands’ Acne Treatments
- Nvidia initiated, Target upgraded: Wall Street’s top analyst calls
- Target price target raised to $191 from $157 at RBC Capital
- Target price target raised to $170 from $145 at BMO Capital
- Target price target raised to $195 from $160 at Telsey Advisory
